Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism.
This report contains market size and forecasts of Dermal Fillers and Botulinum Toxin in global, including the following market information:
Global Dermal Fillers and Botulinum Toxin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dermal Fillers and Botulinum Toxin Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Dermal Fillers and Botulinum Toxin companies in 2021 (%)
The global Dermal Fillers and Botulinum Toxin market was valued at 12400 million in 2021 and is projected to reach US$ 30250 million by 2028, at a CAGR of 13.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dermal Fillers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dermal Fillers and Botulinum Toxin include Allergan, Galderma, LG Life Science, Merz, Medytox, Bloomage, Bohus BioTech, Sinclair Pharma and IMEIK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dermal Fillers and Botulinum Toxin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermal Fillers and Botulinum Toxin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dermal Fillers and Botulinum Toxin Market Segment Percentages, by Type, 2021 (%)
Dermal Fillers
Botulinum Toxin
Global Dermal Fillers and Botulinum Toxin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dermal Fillers and Botulinum Toxin Market Segment Percentages, by Application, 2021 (%)
Medical
Cosmetic
Global Dermal Fillers and Botulinum Toxin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dermal Fillers and Botulinum Toxin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dermal Fillers and Botulinum Toxin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dermal Fillers and Botulinum Toxin revenues share in global market, 2021 (%)
Key companies Dermal Fillers and Botulinum Toxin sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Dermal Fillers and Botulinum Toxin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Galderma
LG Life Science
Merz
Medytox
Bloomage
Bohus BioTech
Sinclair Pharma
IMEIK
Suneva Medical
Teoxane
Luminera
SciVision Biotech
Haohai Bio
Ipsen
LIBP
US World Meds
Hugel
Daewoong